1Shao ZM, Shen ZZ, Liu CH, et al. Curcumin exerts multiple suppressive effects on human breast carcinoma ceUs[J]. Int J Cancer, 2002, 98(2): 234-240.
2Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis[J]. Mol Med, 1998, 4(6): 376-383.
3Chuang SE, Yeh PY, Ku YS, et al. Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NFkappaB), and its attenuation by tarnoxifen, dexamethasone, and cureumin in carcinoma cells [ J ]. Bioehem Pharmacol, 2002, 63 (9) : 1709-1716.
4Anuchapreeda S, Leechanachai P, Smith MM, et al. Modulation of P-glycoprotein expression and function by curcumin in multidrugresistant human KB cells[J]. Biochem Pharmaeol, 2002, 64(4):573-582.
5Sharrna RA, Mclelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extrat on patients with colorectal cancer[J]. Clin Cancer Res, 2001, 7(7): 1894-1900.
6Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcurain, a chemopreventive agent, in patients with high-risk or premaligant lesions[J]. Antieancer Res, 2001, 21(4B): 2895-2900.
7Huang MT, Lou YR, Xie JG, et al. Effect of dietary curcumin and dibenzoylmethane on formation of 7, 12-dimethylbenz [ a ] anthraceneinduced mammary tumors and lymphornas/leukemias in Sencar mice [J]. Carcinogenesis, 1998, 19(9): 1697-1700.
8Han SS, Chtmg ST, Robertson DA, et al. Curcumin causes the growth arrest and alzoptosis of B cell lymphoma by downregulation of egr-1, C-myc, Bcl-XL, NF-kappaB, and p53[J]. Clin Immunol, 1999, 93(2): 152-161.
9Ushida J, Sugie S, Kawabata K, et al. Chernopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats[J]. Jpn J Cancer Res, 2000, 91(9) :893-898.
10Inano H, Onoda M, Inafuku N, et al. lzotent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats[J]. Carcinogenesis, 2000, 21(10): 1835-1841.
